E
Vycor Medical, Inc.
VYCO
$0.0648
-$0.0041-5.95%
E
Sell
3/14/2023Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
D
Sell
11/21/2022Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 11/21/2022 due to a significant decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.0031 to -$0.0087, operating cash flow declined 172.95% from -$28.1 to -$76.7, and the quick ratio declined from 0.08 to 0.06.
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 11/21/2022 due to a significant decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.0031 to -$0.0087, operating cash flow declined 172.95% from -$28.1 to -$76.7, and the quick ratio declined from 0.08 to 0.06.
D
Sell
5/31/2022Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and valuation index.
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and valuation index.
D
Sell
5/13/2022Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 5/13/2022 due to a decline in the valuation index and volatility index.
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 5/13/2022 due to a decline in the valuation index and volatility index.
D
Sell
5/5/2022Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 5/5/2022 due to a large increase in the total return index and valuation index.
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 5/5/2022 due to a large increase in the total return index and valuation index.
D
Sell
4/20/2022Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index and solvency index. The quick ratio declined from 0.08 to 0.07, and debt to equity increased from -0.38 to -0.35.
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index and solvency index. The quick ratio declined from 0.08 to 0.07, and debt to equity increased from -0.38 to -0.35.
D
Sell
3/25/2022Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 3/25/2022 due to an increase in the total return index.
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 3/25/2022 due to an increase in the total return index.
D
Sell
3/7/2022Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 3/7/2022 due to a decline in the volatility index.
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 3/7/2022 due to a decline in the volatility index.
D
Sell
2/18/2022Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 2/18/2022 due to an increase in the volatility index.
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 2/18/2022 due to an increase in the volatility index.
D
Sell
2/3/2022Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 2/3/2022 due to a decline in the total return index and volatility index.
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 2/3/2022 due to a decline in the total return index and volatility index.
D
Sell
11/15/2021Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 11/15/2021 due to an increase in the volatility index and total return index.
Vycor Medical, Inc. (VYCO) was upgraded to D from D- on 11/15/2021 due to an increase in the volatility index and total return index.
D
Sell
11/8/2021Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the solvency index, efficiency index and valuation index.
Vycor Medical, Inc. (VYCO) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the solvency index, efficiency index and valuation index.
D
Sell
3/27/2020Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D from C- on 3/27/2020 due to a significant decline in the efficiency index, volatility index and total return index. Total capital declined 16.04% from -$661.4 to -$767.5, and net income declined 5.44% from -$209.6 to -$221.
Vycor Medical, Inc. (VYCO) was downgraded to D from C- on 3/27/2020 due to a significant decline in the efficiency index, volatility index and total return index. Total capital declined 16.04% from -$661.4 to -$767.5, and net income declined 5.44% from -$209.6 to -$221.
C
Hold
3/17/2020Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to C- from D+ on 3/17/2020 due to an increase in the volatility index and valuation index.
Vycor Medical, Inc. (VYCO) was upgraded to C- from D+ on 3/17/2020 due to an increase in the volatility index and valuation index.
D
Sell
3/2/2020Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to D+ from C- on 3/2/2020 due to a decline in the volatility index.
Vycor Medical, Inc. (VYCO) was downgraded to D+ from C- on 3/2/2020 due to a decline in the volatility index.
C
Hold
2/5/2020Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to C- from D+ on 2/5/2020 due to an increase in the volatility index and total return index.
Vycor Medical, Inc. (VYCO) was upgraded to C- from D+ on 2/5/2020 due to an increase in the volatility index and total return index.
D
Sell
3/29/2019Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D+ from E+ on 3/29/2019 due to a significant increase in the efficiency index, total return index and valuation index.
Vycor Medical, Inc. (VYCO) was upgraded to D+ from E+ on 3/29/2019 due to a significant increase in the efficiency index, total return index and valuation index.
E
Sell
11/14/2018Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 11/14/2018 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from -2.03 to -1.29.
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 11/14/2018 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from -2.03 to -1.29.
D
Sell
5/11/2018Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 5/11/2018 due to a noticeable increase in the valuation index, solvency index and growth index. Debt to equity declined from 3.91 to -1.29, total revenue increased 20.5% from $269.8 to $325.1, and operating cash flow increased 17.88% from -$176.2 to -$144.7.
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 5/11/2018 due to a noticeable increase in the valuation index, solvency index and growth index. Debt to equity declined from 3.91 to -1.29, total revenue increased 20.5% from $269.8 to $325.1, and operating cash flow increased 17.88% from -$176.2 to -$144.7.
E
Sell
4/18/2018Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 4/18/2018 due to a decline in the solvency index, valuation index and growth index. Debt to equity increased from 0.82 to 3.91, operating cash flow declined 73.25% from -$101.7 to -$176.2, and the quick ratio declined from 0.42 to 0.23.
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 4/18/2018 due to a decline in the solvency index, valuation index and growth index. Debt to equity increased from 0.82 to 3.91, operating cash flow declined 73.25% from -$101.7 to -$176.2, and the quick ratio declined from 0.42 to 0.23.
D
Sell
12/12/2017Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 12/12/2017 due to an increase in the volatility index, total return index and valuation index.
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 12/12/2017 due to an increase in the volatility index, total return index and valuation index.
E
Sell
11/27/2017Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 11/27/2017 due to a noticeable decline in the growth index, volatility index and solvency index. Operating cash flow declined 1,417.91% from -$6.7 to -$101.7, debt to equity increased from 0.37 to 0.82, and earnings per share declined from -$0.0193 to -$0.03.
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 11/27/2017 due to a noticeable decline in the growth index, volatility index and solvency index. Operating cash flow declined 1,417.91% from -$6.7 to -$101.7, debt to equity increased from 0.37 to 0.82, and earnings per share declined from -$0.0193 to -$0.03.
D
Sell
11/7/2017Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 11/7/2017 due to an increase in the volatility index and total return index.
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 11/7/2017 due to an increase in the volatility index and total return index.
E
Sell
10/23/2017Downgrade
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 10/23/2017 due to a decline in the valuation index.
Vycor Medical, Inc. (VYCO) was downgraded to E+ from D- on 10/23/2017 due to a decline in the valuation index.
D
Sell
10/3/2017Upgraded
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 10/3/2017 due to an increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.44 to 0.37, and the quick ratio increased from 0.61 to 0.66.
Vycor Medical, Inc. (VYCO) was upgraded to D- from E+ on 10/3/2017 due to an increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.44 to 0.37, and the quick ratio increased from 0.61 to 0.66.
E
Sell
10/21/2016Downgrade
Vycor Medical Inc. (VYCO) was downgraded to E+ from D- on 10/21/2016 due to a decline in the total return index and volatility index.
Vycor Medical Inc. (VYCO) was downgraded to E+ from D- on 10/21/2016 due to a decline in the total return index and volatility index.
D
Sell
10/6/2016Upgraded
Vycor Medical Inc. (VYCO) was upgraded to D- from E+ on 10/6/2016 due to an increase in the volatility index.
Vycor Medical Inc. (VYCO) was upgraded to D- from E+ on 10/6/2016 due to an increase in the volatility index.
E
Sell
9/21/2016Downgrade
Vycor Medical Inc. (VYCO) was downgraded to E+ from D- on 9/21/2016 due to a decline in the total return index and volatility index.
Vycor Medical Inc. (VYCO) was downgraded to E+ from D- on 9/21/2016 due to a decline in the total return index and volatility index.
D
Sell
9/6/2016Upgraded
Vycor Medical Inc. (VYCO) was upgraded to D- from E+ on 9/6/2016 due to an increase in the volatility index.
Vycor Medical Inc. (VYCO) was upgraded to D- from E+ on 9/6/2016 due to an increase in the volatility index.
E
Sell
8/10/2016Downgrade
Vycor Medical Inc. (VYCO) was downgraded to E+ from D- on 8/10/2016 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.37 to 0.76.
Vycor Medical Inc. (VYCO) was downgraded to E+ from D- on 8/10/2016 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.37 to 0.76.
D
Sell
8/8/2016Upgraded
Vycor Medical Inc. (VYCO) was upgraded to D- from E+ on 8/8/2016 due to an increase in the valuation index and growth index.
Vycor Medical Inc. (VYCO) was upgraded to D- from E+ on 8/8/2016 due to an increase in the valuation index and growth index.
E
Sell
4/28/2016Downgrade
Vycor Medical Inc. (VYCO) was downgraded to E+ from D on 4/28/2016 due to a noticeable decline in the growth index, solvency index and efficiency index. Operating cash flow declined 114.24% from -$93.4 to -$200.1, the quick ratio declined from 0.52 to 0.3, and earnings per share declined from -$0.0396 to -$0.0563.
Vycor Medical Inc. (VYCO) was downgraded to E+ from D on 4/28/2016 due to a noticeable decline in the growth index, solvency index and efficiency index. Operating cash flow declined 114.24% from -$93.4 to -$200.1, the quick ratio declined from 0.52 to 0.3, and earnings per share declined from -$0.0396 to -$0.0563.
D
Sell
3/31/2016Upgraded
Vycor Medical Inc. (VYCO) was upgraded to D from D- on 3/31/2016 due to a substantial increase in the growth index. Operating cash flow increased 71.01% from -$322.2 to -$93.4, earnings per share increased from -$0.0546 to -$0.042, and EBIT increased 18.42% from -$509.2 to -$415.4.
Vycor Medical Inc. (VYCO) was upgraded to D from D- on 3/31/2016 due to a substantial increase in the growth index. Operating cash flow increased 71.01% from -$322.2 to -$93.4, earnings per share increased from -$0.0546 to -$0.042, and EBIT increased 18.42% from -$509.2 to -$415.4.
D
Sell
3/11/2016Downgrade
Vycor Medical Inc. (VYCO) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and growth index.
Vycor Medical Inc. (VYCO) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and growth index.
D
Sell
11/13/2015Downgrade
Vycor Medical Inc. (VYCO) was downgraded to D from D+ on 11/13/2015 due to a major decline in the growth index, solvency index and efficiency index. The quick ratio declined from 1.42 to 0.85, debt to equity increased from 0.16 to 0.22, and total capital declined 18.88% from $2.28M to $1.85M.
Vycor Medical Inc. (VYCO) was downgraded to D from D+ on 11/13/2015 due to a major decline in the growth index, solvency index and efficiency index. The quick ratio declined from 1.42 to 0.85, debt to equity increased from 0.16 to 0.22, and total capital declined 18.88% from $2.28M to $1.85M.
D
Sell
8/14/2015Upgraded
Vycor Medical Inc. (VYCO) was upgraded to D+ from D on 8/14/2015 due to a large increase in the growth index and efficiency index.
Vycor Medical Inc. (VYCO) was upgraded to D+ from D on 8/14/2015 due to a large increase in the growth index and efficiency index.
D
Sell
5/15/2015Downgrade
Vycor Medical Inc. (VYCO) was downgraded to D from D+ on 5/15/2015 due to a large decline in the total return index, growth index and efficiency index. Total capital declined 16.31% from $3.21M to $2.69M.
Vycor Medical Inc. (VYCO) was downgraded to D from D+ on 5/15/2015 due to a large decline in the total return index, growth index and efficiency index. Total capital declined 16.31% from $3.21M to $2.69M.
D
Sell
10/8/2014Downgrade
Vycor Medical, Inc (VYCO) was downgraded to D+ from C- on 10/8/2014 due to a major decline in the volatility index.
Vycor Medical, Inc (VYCO) was downgraded to D+ from C- on 10/8/2014 due to a major decline in the volatility index.
C
Hold
8/27/2014Upgraded
Vycor Medical, Inc (VYCO) was upgraded to C- from D+ on 8/27/2014 due to an increase in the volatility index, total return index and growth index.
Vycor Medical, Inc (VYCO) was upgraded to C- from D+ on 8/27/2014 due to an increase in the volatility index, total return index and growth index.
D
Sell
8/13/2014Upgraded
Vycor Medical, Inc (VYCO) was upgraded to D+ from D on 8/13/2014 due to a large increase in the volatility index, solvency index and total return index. The quick ratio increased from 1.11 to 3.2, and debt to equity declined from -11.03 to 1.79.
Vycor Medical, Inc (VYCO) was upgraded to D+ from D on 8/13/2014 due to a large increase in the volatility index, solvency index and total return index. The quick ratio increased from 1.11 to 3.2, and debt to equity declined from -11.03 to 1.79.
D
Sell
5/27/2014Downgrade
Vycor Medical, Inc (VYCO) was downgraded to D from C on 5/27/2014 due to a significant decline in the efficiency index, volatility index and growth index. Total capital declined 782.12% from -$363.5 to $2.48M, and earnings per share declined from -$0.0993 to -$0.0875.
Vycor Medical, Inc (VYCO) was downgraded to D from C on 5/27/2014 due to a significant decline in the efficiency index, volatility index and growth index. Total capital declined 782.12% from -$363.5 to $2.48M, and earnings per share declined from -$0.0993 to -$0.0875.
OTC PK
03/17/2025 3:08PM Eastern
Quotes delayed
